Skip to main content

Table 3 Saturation grid

From: Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity

SYMPTOM SATURATION

s = spontaneous

p = probed

u = don t know

 

Participants

Male (M)/ Female (F)

F

F

M

F

F

F

F

F

F

M

Race / Ethnicity

Hispanic/Latino

Black/Afr ican Am

White

Black/Afr ican Am

Hispanic/Latino

White

Am Indian/AIaskan Nat

Black/Afr ican Am

Asian/Other

Hispanic/Latino

Interview Date

18-Mar

23-Mar

23-Mar

24-Mar

24-Mar

25-Mar

29-Mar

29-Mar

4-Apr

5-Apr

IDs (N = 8)

201–001

201–004

201–006

101–001

201–005

201–003

101–003

101–002

201–008

201–007

n

%

n

%

n

%

          
 

OVERALL

SPONTANEOUS

PROBED

          

Joint/bone pain, stiffness or swelling (arthritis, arthritislike symptoms)

10

100%

10

100%

0

0%

S

s

s

s

s

s

s

s

s

s

Fatigue

10

100%

5

50%

5

50%

S

s

P

P

P

P

s

s

s

P

Swelling

9

90%

6

60%

3

30%

P

p

s

s

s

s

p

s

s

 

Weakness

9

90%

2

20%

7

70%

P

p

s

p

p

p

p

 

s

P

Difficulty breathing/shortness of breath

8

80%

5

50%

3

30%

P

 

s

p

s

s

s

 

p

S

Skin problems (e.g., rash, pigmentation)

8

80%

5

50%

3

30%

s

 

u

s

s

s

p

s

p

P

Chest pain

7

70%

2

20%

5

50%

p

  

p

p

s

u

s

p

P

Tiredness

6

60%

4

40%

2

20%

s

 

p

 

s

s

 

u

p

s

Hair loss

6

60%

2

20%

4

40%

p

p

p

s

  

u

s

p

u

Muscle pain, aching or stiffness

5

50%

2

20%

3

30%

p

  

p

s

p

s

u

  

Fever

5

50%

2

20%

3

30%

s

s

 

p

 

p

   

p

Other*

7

70%

7

70%

0

0%

s

s

s

s

s

s

s

 

s

s